CROI 2016 Program at a Glance

Disclosure Information

DISCLOSURE OF FINANCIAL RELATIONSHIPS WITH COMMERCIAL CONCERNS Disclosure information is presented generally as submitted by the corresponding presenting abstract author or invited speaker. The authors and speakers below provided all relevant disclosures of financial relationships with commercial entities for themselves and their spouses or partners, as well as funding provided to their institutions.

Dicker, Ira Self: Employee of Bristol-Myers Squibb Dolling, David Institution: Research support from GlaxoSmithKline, Gilead Sciences, and Boehringer Ingelheim Eckard, Allison Self: Advisor and speaker for Gilead Sciences Institution: Research funding from GlaxoSmithKline, Cubist Pharmaceuticals, and Bristol-Myers Squibb Eley,Timothy Self: Employee and shareholder of Bristol-Myers Squibb Institution: Bristol-Myers Squibb owned the rights to BMS66068 when this study was conducted Erlandson, Kristine Self: Research funding from Gilead Sciences Eron, Joseph Self: Consultant to Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, andViiV Healthcare Institution: Research grants from Janssen, Gilead Sciences,ViiV Healthcare, and AbbVie Fidler, Sarah Self: Research funding from GSK and MSD Gallant, Joel Self: Consulting and advisory boards: Bristol-Myers Squibb, Gilead Sciences, JanssenTherapeutics, Merck & Co, andViiV Healthcare Institution: Grant funding from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, Merck & Co, and Sangamo Garrett, Katy Institution: Research grant from Gilead Sciences Gatell, Jose María Self: Honoraria for lectures from AbbVie, Janssen, Gilead,ViiV, and Bristol-Myers Squibb Institution: Grant funding fromMSD, AbbVie, Janssen, Gilead,ViiV, and Bristol-Myers Squibb Gaur, Aditya Self: Study investigator on clinical trials sponsored by Gilead Sciences Giaquinto, Carlo Self: Advisor toViiV, Merk, Gilead, speaker travel fromViiV Healthcare Instruction: Grants fromViiV Healthcare, Gilead, Bristol-Myers Squibb, and Johnson and Johnson

Calcagno, Andrea Self: Research grants from Gilead and Bristol-Myers Squibb; speaker’s honoraria from AbbVie, Bristol- Myers Squibb, Gilead, MSD, Janssen-Cilag, andViiV Chang, Larry Self: Advisor, stockholder, entitled to royalties, emocha Mobile Health Charpentier, Charlotte Honorarium fromMSD, Gilead,ViiV, Bristol-Myers Squibb, and Janssen Chen, Beatrice Institution: Research funding from Bayer, Medicines 360, and AgileTherapeutics Chockalingam, Leela Self: Advisor, Gilead Sciences Christensen, Stefan Self: Consulting or speaker grant from AbbVie, Bristol-Myers Squibb, Gilead, Hexal, Janssen-Cilag, MSD, Reckitt-Benckiser,ViiV Healthcare Cohen, Stephanie Self: Study drug and drug-level testing from Gilead Connick, Elizabeth Self: DSMB for a study partially funded by Sangamo Biosciences Cooper, Curtis Self: Advisor and research funding from Gilead and Self: Travel grants, honoraria, and study grants from Gilead Sciences, Janssen-Cilag, Merck Sharp & Dohme-Chibret, andViiV Healthcare Cranston, Ross Spouse or Partner: Consultant for Novicol Life Sciences and ABIVAX; research grants from Janssen R&D andViiV Healthcare Cysique, Lucette Self: Research support fromMSD, AbbVie Institution: Research support from AbbVie D’Aquila, Richard Self: Honoraria from Janssen Scientific Affairs, JanssenTherapeutics, and Clinical Care Options DeJesus, Edwin Self: Advisory board and speaker fees from Janssen and Gilead Science Derby, Nina Institution: Received Poly-ICLC from Oncovir AbbVie; advisor for Merck Costagliola, Dominique

Abram, Michael Self: Employee and stockholder, Gilead Sciences Allavena, Clotilde Self: Travel grants or hononaria fromMylan, Bristol-Myers Squibb, Gilead Sciences, Janssen, MSD, andViiV Healthcare Altfeld, Marcus Self: Speaker honorarium fromMSD, Bristol-Myers Squibb, Jansen & Jansen, and Gilead Althoff, Keri Self: Medical Advisory Board for Gilead Sciences Ananworanich, Jintanat Self: Advisory boards forViiV Healthcare and Merck Anderson, Peter Self: Contract work and study drug donation from Gilead Sciences Asmuth, David Self: Grant and travel funds support from Entera Health Bernardino, Jose Self: Personal fees from Bristol-Myers Squibb, Gilead Sciences,ViiV healthcare, MSD, and Janssen Berry, Stephen Self: Advisor for Bristol-Myers Squibb Bisson, Gregory Self: Endpoint adjudicator for a post-marketing surveillance study for Pfizer; consultant for Celgene Boettiger, David Self: Funding from Gilead Australia Boyd, Mark Self: Research funding from AbbVie, Merck, and Gilead; honoraria for service on HIV advisory boards fromMerck, Gilead, andViiV Healthcare; honoraria for educational presentations from AbbVie, Bristol- Myers Squibb, Boehringer Ingelheim Brinkman, Kees Self: Advisory boards for AbbVie,ViiV Healthcare, Gilead, Janssen, and Bristol-Myers Squibb Brockmeyer, Norbert Self: Congress sponsorship and research funding from Gilead, MSD, Sanofi Pasteur,ViiV Healthcare, and GSK Brophy, Jason Self: Educational Grant from AbbVie Butt, Adeel Institution: Grants funding from AbbVie and Gilead

Disclsoure Information

CROI 2016 128

Made with FlippingBook HTML5